Orchard Therapeutics Expands Leadership Team with Appointments of Head of Corporate Communications and Head of Human Resources
August 28, 2018 07:00 ET
|
Orchard Therapeutics
BOSTON and LONDON, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a leading commercial-stage company dedicated to transforming the lives of patients with rare diseases through innovative...
Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline
August 13, 2018 04:00 ET
|
Orchard Therapeutics
Proceeds to advance three late-stage programs towards registration, prepare for commercialization and progress the company’s gene therapy platform BOSTON and LONDON, Aug. 13, 2018 (GLOBE NEWSWIRE)...
Orchard Therapeutics Appoints Jon Ellis to Board of Directors
August 02, 2018 04:00 ET
|
Orchard Therapeutics
BOSTON and LONDON, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through...
Orchard Therapeutics Appoints Joanne Beck, Ph.D. to Board of Directors
July 09, 2018 04:00 ET
|
Orchard Therapeutics
BOSTON and LONDON, July 09, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through...
Orchard Therapeutics Appoints Jim Geraghty as Chairman of its Board of Directors
June 29, 2018 03:00 ET
|
Orchard Therapeutics
BOSTON and LONDON, June 29, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through...
Orchard Therapeutics Announces Appointments of Marc Dunoyer and Charlie Rowland to Board of Directors
June 07, 2018 05:59 ET
|
Orchard Therapeutics
BOSTON and LONDON, June 07, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a leading commercial stage biotech company dedicated to transforming the lives of patients with rare diseases through...
Orchard Therapeutics’ OTL-200 Receives Rare Pediatric Disease Designation from FDA for Treatment of Metachromatic Leukodystrophy
May 03, 2018 03:00 ET
|
Orchard Therapeutics
BOSTON and LONDON, May 03, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a leading commercial stage company dedicated to transforming the lives of patients with rare diseases through innovative...
Orchard Therapeutics Expands US Presence with New Corporate Office in Boston
April 24, 2018 08:00 ET
|
Orchard Therapeutics
BOSTON and LONDON, April 24, 2018 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a leading commercial and clinical-stage company dedicated to transforming the lives of patients with rare diseases through...
GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics
April 12, 2018 03:00 ET
|
Orchard Therapeutics
Agreement strengthens Orchard’s position as a global leader in gene therapy for rare diseasesGSK takes 19.9% equity stake in Orchard and seat on board LONDON, April 12, 2018 (GLOBE NEWSWIRE) -- ...